Pharma Reaserch Prod Co Ltd (214450) — Cash Flow Quality Index
Pharma Reaserch Prod Co Ltd (214450) has a Cash Flow Quality Index of 1.89x as of December 2025. Operating cash flow of ₩61.53 Billion exceeds net income of ₩32.57 Billion, indicating high earnings quality where cash backs reported profits. Explore Pharma Reaserch Prod Co Ltd (214450) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharma Reaserch Prod Co Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Pharma Reaserch Prod Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Pharma Reaserch Prod Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year earnings quality comparison for Pharma Reaserch Prod Co Ltd. For live market cap and the full company financial profile, see 214450 market cap.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.11x | ₩183.16 Billion | ₩165.12 Billion | ▼ -29.4% |
| 2024 | 1.57x | ₩139.88 Billion | ₩89.01 Billion | ▲ +81.9% |
| 2023 | 0.86x | ₩64.95 Billion | ₩75.18 Billion | ▼ -40.3% |
| 2022 | 1.45x | ₩59.40 Billion | ₩41.04 Billion | ▲ +3.7% |
| 2021 | 1.40x | ₩65.30 Billion | ₩46.76 Billion | ▲ +41.3% |
| 2020 | 0.99x | ₩32.39 Billion | ₩32.77 Billion | ▼ -14.5% |
| 2019 | 1.16x | ₩19.27 Billion | ₩16.67 Billion | ▲ +220.2% |
| 2018 | 0.36x | ₩5.20 Billion | ₩14.41 Billion | ▼ -45.3% |
| 2017 | 0.66x | ₩8.56 Billion | ₩12.96 Billion | ▲ +11.9% |
| 2016 | 0.59x | ₩8.16 Billion | ₩13.83 Billion | ▼ -52.6% |
| 2015 | 1.24x | ₩16.02 Billion | ₩12.88 Billion | — |